Overexpression of miRNA-125a-5p inhibits the growth and angiogenesis of hepatocellular carcinoma by regulating the expression of VEGF-A

References

• Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet (London, England). 2003;362:1907–1917.
   PubMed Web of Science ®Google Scholar
• Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis. 2005;25:143–154.
   PubMed Web of Science ®Google Scholar
• Semela D, Dufour JF. Angiogenesis and hepatocellular carcinoma. J Hepatol. 2004; 41:864–880.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000; 407:249–257.
   PubMed Web of Science ®Google Scholar
• O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997; 88:277–285.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Han J, Yang X, et al. Pigment epithelium-derived factor inhibits angiogenesis and growth of gastric carcinoma by down-regulation of VEGF. Oncol Rep. 2011;26:681–686.
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiostatin and endostatin: angiogenesis inhibitors in blood and stroma. US: Springer; 2008.
   Google Scholar
• Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology. 2005;69:4–10.
   PubMed Web of Science ®Google Scholar
• Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009; 136:642–655.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li Z, Wu L, et al. MiRNA-125a-5p: a regulator and predictor of gefitinib's effect on nasopharyngeal carcinoma. Cancer Cell Int. 2014; 14:24.
   PubMed Web of Science ®Google Scholar
• Huang B, Luo W, Sun L, et al. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells. Int J Oncol. 2013; 42:1734–1742.
   PubMed Web of Science ®Google Scholar
• Viallard C, Larrivee B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017; 20:409–426.
   PubMed Web of Science ®Google Scholar
• Kim JK, Noh JH, Jung KH, et al. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology (Baltimore, MD). 2013; 57:1055–1067.
   PubMed Web of Science ®Google Scholar
• Hsieh TH, Hsu CY, Tsai CF, et al. miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis. Oncotarget. 2015; 6:494–509.
   PubMedGoogle Scholar
• Xu Y, Huang Z, Liu Y. Reduced miR-125a-5p expression is associated with gastric carcinogenesis through the targeting of E2F3. Mol Med Rep. 2014; 10:2601–2608.
   PubMed Web of Science ®Google Scholar
• Tang H, Li RP, Liang P, et al. miR-125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway. Oncol Lett. 2015;10:681–686.
   PubMed Web of Science ®Google Scholar
• Melton DW, Lei X, Gelfond JA, et al. Dynamic macrophage polarization-specific miRNA patterns reveal increased soluble VEGF receptor 1 by miR-125a-5p inhibition. Physiol Genom. 2016; 48:345–360.
   PubMed Web of Science ®Google Scholar
• Pogue AI, Cui JG, Li YY, et al. Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci Lett. 2010;476:18–22.
   PubMed Web of Science ®Google Scholar
• Kerbel RS. Tumor angiogenesis. N Engl J Med. 2008; 358:2039–2049.
   PubMed Web of Science ®Google Scholar
• Ronca R, Benkheil M, Mitola S, et al. Tumor angiogenesis revisited: regulators and clinical implications. Med Res Rev. 2017; 37:1231–1274.
   PubMed Web of Science ®Google Scholar
• Leppanen P, Koota S, Kholova I, et al. Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoprotein-receptor/apolipoprotein B48-deficient mice. Circulation. 2005; 112:1347–1352.
   PubMed Web of Science ®Google Scholar
• Dellinger MT, Brekken RA. Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endothelium. PLoS One. 2011;6:e28947.
   PubMed Web of Science ®Google Scholar
• Nishida N, Mimori K, Fabbri M, et al. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. Clin Cancer Res Off J Am Assoc Cancer Res. 2011; 17:2725–2733.
   PubMed Web of Science ®Google Scholar
• Potenza N, Mosca N, Zappavigna S, et al. MicroRNA-125a-5p is a downstream effector of sorafenib in its antiproliferative activity toward human hepatocellular carcinoma cells. J Cell Physiol. 2017;232:1907–1913.
   PubMed Web of Science ®Google Scholar
• Maity G, Chakraborty J, Ghosh A, et al. Aspirin suppresses tumor cell-induced angiogenesis and their incongruity. J Cell Commun Signal. 2019;Jan 4.
   PubMedGoogle Scholar
• Silva TCPD, Silva MG, Shinjo SK. Relevance of serum angiogenic cytokines in adult patients with dermatomyositis. Adv Rheumatol.. 2018;58:17.
   PubMedGoogle Scholar
• Sun W, Wang X, Li J, et al. MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathway. Cell Death Dis. 2018;9:438.
   PubMed Web of Science ®Google Scholar
• Zhang L, Liao Y, Tang L. MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer. J Exp Clin Cancer Res.. 2019;38:
   Web of Science ®Google Scholar
• Liang TS, Zheng YJ, Wang J, et al. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2. J Exp Clin Cancer Res.. 2019;38:97.
   PubMed Web of Science ®Google Scholar
• Wang R, Sun Y, Yu W, et al. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT. J Exp Clin Cancer Res. 2019;38:20.
   PubMed Web of Science ®Google Scholar
• Satishchandran A, Ambade A, Rao S, et al. MicroRNA 122, regulated by GRLH2, protects livers of mice and patients from ethanol-induced liver disease. Gastroenterology. 2018;154:238–252.
   Web of Science ®Google Scholar
• Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene. 2006; 25:2537–2545.
   PubMed Web of Science ®Google Scholar
• Jiang J, Gusev Y, Aderca I, et al. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res Off J Am Assoc Cancer Res. 2008;14:419–427.
   PubMed Web of Science ®Google Scholar
• Nienhüser H, Schmidt T. Angiogenesis and anti-angiogenic therapy in gastric cancer. Int J Mol Sci. 2018;19:43.
   Web of Science ®Google Scholar
• Shi H, Bi H, Sun X, et al. Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway. Mol Med Rep.. 2018;17:4327–4336.
   PubMed Web of Science ®Google Scholar
• Tomida C, Yamagishi N, Nagano H, et al. VEGF pathway-targeting drugs induce evasive adaptation by activation of neuropilin-1/cMet in colon cancer cells. Int J Oncol.. 2018;52:1350.
   PubMed Web of Science ®Google Scholar